Article

Comparison of next-generation sequencing and cobas® EGFR Mutation Test v2 in detecting EGFR mutations

2022-05-12

Abstract excerpt

<h4>Purpose: </h4> Targeting oncogenic driver mutations, such as sensitizing mutations in the epidermal growth factor receptor gene ( EGFR ), significantly improves the prognosis of patients with advanced non-squamous non-small-cell lung cancer (NS-NSCLC). As the number of genetic mutations that must be tested increases, the Oncomine Dx Target Test (ODxTT), which can simultaneously detect multiple cancer-related g...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d472389d-2389-5d4b-9739-e129aa23792d
DOI: 10.21203/rs.3.rs-1584037/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Comparison of next-generation sequencing and cobas® EGFR Mutation Test v2 in detecting EGFR mutationsDOI 10.21203/rs.3.rs-1584037/v2Read

Comparison of next-generation sequencing and cobas EGFR mutation test v2 in detecting EGFR mutations.Semantic proximity Read

Possible False Results With cobas® EGFR Mutation Test v2 and Oncomine Dx Target Test for EGFR Mutation.Semantic proximity Read

Comparison of the analytical performance between the Oncomine Dx Target Test and a conventional single gene test for epidermal growth factor receptor mutation in non-small cell lung cancer.Semantic proximity Read

Real-world data on NGS using the Oncomine DxTT for detecting genetic alterations in non-small-cell lung cancer: WJOG13019L.Semantic proximity Read

A profile on cobas® EGFR Mutation Test v2 as companion diagnostic for first-line treatment of patients with non-small cell lung cancerSemantic proximity Read

Simulation analysis of EGFR mutation detection: Oncomine Dx target test and AmoyDx panel impact on lung cancer treatment decisions.Semantic proximity Read

Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer.Semantic proximity Read

Clinical utility of the Oncomine Dx Target Test multi-CDx system and the possibility of utilizing those original sequence data.Semantic proximity Read

The association of EGFR amplification with aberrant exon 20 insertion report using the cobas EGFR Mutation Test v2.Semantic proximity Read

Analytical Performance of a Highly Sensitive System to Detect Gene Variants Using Next-Generation Sequencing for Lung Cancer Companion DiagnosticsSemantic proximity Read

Comparison of cross-platform technologies for EGFR T790M testing in patients with non-small cell lung cancerSemantic proximity Read

Analytical performance of a highly sensitive system to detect gene variants using next-generation sequencing for lung cancer companion diagnosticsSemantic proximity Read